Literature DB >> 29882045

Evaluation of radiation-related invasion in primary patient-derived glioma cells and validation with established cell lines: impact of different radiation qualities with differing LET.

M Wank1,2,3, D Schilling1,2,3, J Reindl4, B Meyer5, J Gempt5, S Motov5, F Alexander2, J J Wilkens2, J Schlegel6, T E Schmid1,2, S E Combs7,8,9.   

Abstract

PURPOSE: Glioblastoma multiforme (GBM) is the most common primary brain tumor and has a very poor overall prognosis. Multimodal treatment is still inefficient and one main reason is the invasive nature of GBM cells, enabling the tumor cells to escape from the treatment area causing tumor progression. This experimental study describes the effect of low- and high-LET irradiation on the invasion of primary GBM cells with a validation in established cell systems.
METHODS: Seven patient derived primary GBM as well as three established cell lines (LN229, LN18 and U87) were used in this study. Invasion was investigated using Matrigel® coated transwell chambers. Irradiation was performed with low- (X-ray) and high-LET (alpha particles) radiation. The colony formation assay was chosen to determine the corresponding alpha particle dose equivalent to the X-ray dose.
RESULTS: 4 Gy X-ray irradiation increased the invasive potential of six patient derived GBM cells as well as two of the established lines. In contrast, alpha particle irradiation with an equivalent dose of 1.3 Gy did not show any effect on the invasive behavior. The findings were validated with established cell lines.
CONCLUSION: Our results show that in contrast to low-LET irradiation high-LET irradiation does not enhance the invasion of established and primary glioblastoma cell lines. We therefore suggest that high-LET irradiation could become an alternative treatment option. To fully exploit the benefits of high-LET irradiation concerning the invasion of GBM further molecular studies should be performed.

Entities:  

Keywords:  Brain tumor; Glioblastoma multiforme; Invasion; Irradiation; Primary cells; Survival

Mesh:

Year:  2018        PMID: 29882045     DOI: 10.1007/s11060-018-2923-4

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  32 in total

1.  Carbon ion irradiation suppresses metastatic potential of human non-small cell lung cancer A549 cells through the phosphatidylinositol-3-kinase/Akt signaling pathway.

Authors:  Toshiyuki Ogata; Teruki Teshima; Miho Inaoka; Kazumasa Minami; Takahiro Tsuchiya; Masaru Isono; Yoshiya Furusawa; Nariaki Matsuura
Journal:  J Radiat Res       Date:  2011-02-19       Impact factor: 2.724

2.  IL-8 is a mediator of NF-κB induced invasion by gliomas.

Authors:  Baisakhi Raychaudhuri; Michael A Vogelbaum
Journal:  J Neurooncol       Date:  2010-06-25       Impact factor: 4.130

Review 3.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

4.  In vitro evaluation of combined temozolomide and radiotherapy using X  rays and high-linear energy transfer radiation for glioblastoma.

Authors:  Lara Barazzuol; Raj Jena; Neil G Burnet; Jonathan C G Jeynes; Michael J Merchant; Karen J Kirkby; Norman F Kirkby
Journal:  Radiat Res       Date:  2012-04-02       Impact factor: 2.841

Review 5.  Recurrent glioblastoma multiforme: a review of natural history and management options.

Authors:  Lewis C Hou; Anand Veeravagu; Andrew R Hsu; Victor C K Tse
Journal:  Neurosurg Focus       Date:  2006-04-15       Impact factor: 4.047

Review 6.  The WHO classification of tumors of the nervous system.

Authors:  Paul Kleihues; David N Louis; Bernd W Scheithauer; Lucy B Rorke; Guido Reifenberger; Peter C Burger; Webster K Cavenee
Journal:  J Neuropathol Exp Neurol       Date:  2002-03       Impact factor: 3.685

Review 7.  Long-term survival with glioblastoma multiforme.

Authors:  Dietmar Krex; Barbara Klink; Christian Hartmann; Andreas von Deimling; Torsten Pietsch; Matthias Simon; Michael Sabel; Joachim P Steinbach; Oliver Heese; Guido Reifenberger; Michael Weller; Gabriele Schackert
Journal:  Brain       Date:  2007-09-04       Impact factor: 13.501

8.  Post-radiation increase in VEGF enhances glioma cell motility in vitro.

Authors:  Whoon Jong Kil; Philip J Tofilon; Kevin Camphausen
Journal:  Radiat Oncol       Date:  2012-02-22       Impact factor: 3.481

Review 9.  Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both?

Authors:  Constantin Dreher; Daniel Habermehl; Oliver Jäkel; Stephanie E Combs
Journal:  Radiat Oncol       Date:  2017-12-27       Impact factor: 3.481

10.  Irradiation differentially affects substratum-dependent survival, adhesion, and invasion of glioblastoma cell lines.

Authors:  N Cordes; B Hansmeier; C Beinke; V Meineke; D van Beuningen
Journal:  Br J Cancer       Date:  2003-12-01       Impact factor: 7.640

View more
  7 in total

1.  Development of a model for fibroblast-led collective migration from breast cancer cell spheroids to study radiation effects on invasiveness.

Authors:  Jia Mei; Claudia Böhland; Anika Geiger; Iris Baur; Kristina Berner; Steffen Heuer; Xue Liu; Laura Mataite; M Camila Melo-Narváez; Erdem Özkaya; Anna Rupp; Christian Siebenwirth; Felix Thoma; Matthias F Kling; Anna A Friedl
Journal:  Radiat Oncol       Date:  2021-08-19       Impact factor: 3.481

Review 2.  Human Glioma Migration and Infiltration Properties as a Target for Personalized Radiation Medicine.

Authors:  Michaela Wank; Daniela Schilling; Thomas E Schmid; Bernhard Meyer; Jens Gempt; Melanie Barz; Jürgen Schlegel; Friederike Liesche; Kerstin A Kessel; Benedikt Wiestler; Stefanie Bette; Claus Zimmer; Stephanie E Combs
Journal:  Cancers (Basel)       Date:  2018-11-20       Impact factor: 6.639

3.  Diverse metabolic response of cancer cells treated with a 213Bi-anti-EGFR-immunoconjugate.

Authors:  Benedikt Feuerecker; Philipp Biechl; Christof Seidl; Frank Bruchertseifer; Alfred Morgenstern; Markus Schwaiger; Wolfgang Eisenreich
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

4.  Parenteral high‑dose ascorbate - A possible approach for the treatment of glioblastoma (Review).

Authors:  Olga Renner; Markus Burkard; Holger Michels; Claudia Vollbracht; Tobias Sinnberg; Sascha Venturelli
Journal:  Int J Oncol       Date:  2021-05-06       Impact factor: 5.650

Review 5.  Molecular Mechanisms and Clinical Challenges of Glioma Invasion.

Authors:  Tomoya Oishi; Shinichiro Koizumi; Kazuhiko Kurozumi
Journal:  Brain Sci       Date:  2022-02-20

6.  CeCILE - An Artificial Intelligence Based Cell-Detection for the Evaluation of Radiation Effects in Eucaryotic Cells.

Authors:  Sarah Rudigkeit; Julian B Reindl; Nicole Matejka; Rika Ramson; Matthias Sammer; Günther Dollinger; Judith Reindl
Journal:  Front Oncol       Date:  2021-06-30       Impact factor: 6.244

Review 7.  Perspectives of cellular communication through tunneling nanotubes in cancer cells and the connection to radiation effects.

Authors:  Nicole Matejka; Judith Reindl
Journal:  Radiat Oncol       Date:  2019-12-03       Impact factor: 3.481

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.